Monday, November 5, 2012

• Pfizer to Pay $1.25 Million to IsisZacks (Mon, Nov 5)
• Why Did This Drugmaker's Earnings Displease Investors?at Motley Fool (Mon, Nov 5)
• BioMarin Stock Soars On Positive Drug Dataat Investor's Business Daily (Mon, Nov 5)

Saturday, November 3, 2012

• Pfizer Makes Payment To Isis, AtriCure Survives Miss: Healthcare Business Updateat Wall St. Cheat Sheet (Sat, Nov 3)

Friday, November 2, 2012

• Pfizer Pays Isis Pharma and 3 Dow Movers Making Market Wavesat Wall St. Cheat Sheet (Fri, Nov 2)
• Biotech Stock Mailbag: More Amarin, MannKind, Orexigenat TheStreet (Fri, Nov 2)

Thursday, November 1, 2012

• A Simple Path to Biotechnology Winnersat Motley Fool (Thu, Nov 1)

Wednesday, October 31, 2012

• Isis Means Business With This New Treatmentat Wall St. Cheat Sheet (Wed, Oct 31)
• Isis Sees Impressive Phase I Data, HealthSouth’s Downgrade: Healthcare Business Wrapat Wall St. Cheat Sheet (Wed, Oct 31)

Friday, October 26, 2012

• Generics Hit Sanofi AgainZacks (Fri, Oct 26)

Thursday, October 25, 2012

• Did Shares Of Isis Finally Bottom Out?at Seeking Alpha (Thu, Oct 25)

Wednesday, October 24, 2012

• Aegerion's Lomitapide - FDA Approval, Strong Launch, Stock Price Increase Anticipatedat Seeking Alpha (Wed, Oct 24)
• Cramer's Top Stock Picks: PPG GLD ISISat TheStreet (Wed, Oct 24)

Tuesday, October 23, 2012

• Sarepta Part I: The Possibility Of An Accelerated Approval Of Eteplirsenat Seeking Alpha (Tue, Oct 23)
• BSD Medical Shares Pop, Isis Receives Payment From Alnylam: Healthcare Business Wrapat Wall St. Cheat Sheet (Tue, Oct 23)
• Cramer's 'Mad Money' Recap: Bright Spotsat TheStreet (Tue, Oct 23)
• Cramer: Down 30% in 5 Days, What Gives With 'This Stock'?at CNBC (Tue, Oct 23)
• [video] ISIS CEO: We're Confident in Kynamroat CNBC (Tue, Oct 23)
• 5 of Last Week's Biggest Losersat Motley Fool (Tue, Oct 23)
• Isis Pharma gets $1.1M payment from AlnylamAP (Tue, Oct 23)
• Could Success Be Written in These Stocks' Genes?at Motley Fool (Tue, Oct 23)

Monday, October 22, 2012

• FDA Panel Backs Isis' KynamroZacks (Mon, Oct 22)
• This Week in Biotechat Motley Fool (Mon, Oct 22)

Sunday, October 21, 2012

• Healthcare Biz Recap: Sanofi & Isis Get FDA Marketing Okay, Healthways Survives Reportat Wall St. Cheat Sheet (Sun, Oct 21)

Friday, October 19, 2012

• 3 Horrendous Health-Care Stocks This Weekat Motley Fool (Fri, Oct 19)

Add ISIS News to My Yahoo!